← Open Payments lookup

NEETA VORST: Open Payments

NPI 1801399555 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,333 in 163 payments from 24 companies in 2025. Trend: 2023 $4,581 · 2024 $2,619 · 2025 $3,333

Food & beverage: $3,075Education: $258
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP21$578
GENZYME CORPORATION20$426
Regeneron Healthcare Solutions, Inc.23$355
GlaxoSmithKline, LLC.23$325
Mallinckrodt Hospital Products Inc.14$293
ANI Pharmaceuticals, Inc.9$159
Boehringer Ingelheim Pharmaceuticals, Inc.8$149
Actelion Pharmaceuticals US, Inc.4$147
United Therapeutics Corporation4$108
La Jolla Pharmaceutical Company5$108

Products named: DUPIXENT, TEZSPIRE, ACTHAR, NUCALA, FASENRA, PURIFIED CORTROPHIN GEL, Tyvaso, GIAPREZA.

Industry payments across VA — which companies pay providers there.